Is peroral endoscopic myotomy (POEM) helpful for Type 1 achalasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

POEM for Type 1 Achalasia: Efficacy and Considerations

For Type 1 achalasia, peroral endoscopic myotomy (POEM) is highly efficacious with symptom improvement rates of 89-97%, but pneumatic dilation (PD) and laparoscopic Heller myotomy (LHM) remain first-line treatments with less morbidity and cost. 1

Treatment Options for Type 1 Achalasia

  • According to the American Gastroenterological Association (AGA) guidelines, both pneumatic dilation (PD) and laparoscopic Heller myotomy (LHM) are highly efficacious first-line treatments for Type 1 achalasia, with PD having less morbidity and cost 1, 2
  • POEM has demonstrated high efficacy in randomized controlled trials compared to PD for Type 1 achalasia, but only short-term data is available 1
  • Clinical success rates for POEM across all achalasia types range from 89-97% in large uncontrolled trials with follow-up periods of 11-36 months 1

Efficacy of POEM for Type 1 Achalasia

  • POEM significantly reduces Eckardt symptom scores from pre-procedure means of 6.8 to post-procedure means of 1.2, indicating substantial symptom improvement 3
  • Objective measurements show POEM reduces lower esophageal sphincter pressure by approximately 66% and improves timed barium esophagram column height by 80% 3
  • In multicenter studies, 97% of patients achieved symptom remission at 3 months post-POEM, with 82% maintaining remission at 12 months 4

Important Considerations and Limitations

  • Post-POEM gastroesophageal reflux is a significant concern, with studies showing esophagitis in up to 19-33% of patients and abnormal pH studies in 47.8% of patients 1, 3
  • Patients should be advised about the potential need for indefinite proton pump inhibitor therapy and/or surveillance endoscopy before undergoing POEM 1, 2
  • There is insufficient data on the efficacy of POEM for advanced esophageal dilation, sigmoidization, epiphrenic diverticulum, and hiatal hernia in Type 1 achalasia 1

Predictive Factors for POEM Outcomes

  • Advanced achalasia stage and long symptom duration are independent predictive factors for poor treatment outcomes after POEM 5
  • Post-POEM esophageal diameter >3 cm is associated with treatment failure as assessed by Eckardt score and timed barium esophagram 5

Procedural Considerations

  • POEM should be performed by experienced physicians in high-volume centers, with an estimated 20-40 procedures needed to achieve competence 2
  • Minor adverse events include capno/pneumoperitoneum (30.6%), capno/pneumothorax (11.0%), and subcutaneous emphysema (31.6%), while major adverse events are rare (mediastinal leak 0.3%, bleeding 1.1%) 3

Treatment Algorithm for Type 1 Achalasia

  1. For initial treatment of uncomplicated Type 1 achalasia: Consider PD or LHM as first-line options due to established long-term efficacy and lower costs 1
  2. Consider POEM as an alternative first-line treatment when:
    • Expertise is available at a high-volume center 2
    • Patient understands and accepts the higher risk of post-procedure reflux 1, 2
  3. POEM may be particularly valuable for Type 1 achalasia patients with:
    • Previous failed Heller myotomy (90% success rate in this population) 6
    • Need for retreatment after PD 2

In conclusion, while POEM is effective for Type 1 achalasia with high success rates, the AGA guidelines still recommend PD or LHM as preferred initial treatments due to their established long-term efficacy, lower costs, and lower reflux rates. POEM remains an excellent option when performed by experienced endoscopists, particularly in cases of previous treatment failure.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.